• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation on neutralizing efficacy against verotoxin and resistance to protease of bovine immune colostral antibody in mice and beagle dogs

Research Project

Project/Area Number 20580315
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Applied animal science
Research InstitutionAzabu University

Principal Investigator

YAMAMOTO Shizuo  Azabu University, 環境保健学部, 教授 (40130900)

Co-Investigator(Kenkyū-buntansha) FUKUYAMA Masafumi  麻布大学, 環境保健学部, 教授 (40075932)
FURUHATA Katsunori  麻布大学, 環境保健学部, 准教授 (00308305)
KURIBAYASHI Takashi  麻布大学, 環境保健学部, 講師 (00386799)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2010: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2009: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2008: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Keywords機能性物質 / 受動免疫 / 腸管出血性大腸菌 / 初乳抗体 / ウシ / 感染症 / 免疫学 / イヌ
Research Abstract

The bovine colostral antibody against verotoxin2 (VT2) was not inactivated after 2 hours after oral administration. However, the activity of serum antibody reduced 15% of prior administration in the small intestine of beagle dogs. Furthermore, the antibody activity of S-IgA did not change; however, the activity of IgG and IgM antibodies decreased after 2 hours of oral administration. With oral administration of bovine colostral whey without antibody in beagle dogs inoculated Escherichia coli (E.coli) O157:H7 producing VT2, the amount of VT2 in feces decreased gradually after administration and increased again at 5 days after inoculation, while bovine colostral antibody significantly reduced the amount of VT2 in feces the day after oral administration of bovine colostral antibody. Mice were administered orally each immunoglobulin class antibody isolated from bovine colostral whey obtained from cows immunized with VT2, serum antibody or bovine colostral antibody at 1h after administration of VT2. All mice died after administration of sterilized saline as control. The survival rate was 93.3% after administration of S-IgA or IgM class antibody, or bovine colostral antibody. The survival rates for IgG class antibody and serum antibody were 80% and 60%, respectively. These results suggest that bovine colostral antibody against VT neutralized the activity of in small intestine by resistance to protease.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (13 results)

All 2010 2009 2008 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (10 results) Remarks (1 results)

  • [Journal Article] Bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157 : H7 : Resistance to proteases and effects on verotoxin 2 in small intestine of beagle dogs.2009

    • Author(s)
      Kuribayashi T., Seita T., Matsumoto M., Furuhata K., Tagata K., Yamamoto S.
    • Journal Title

      Comp.Med. 59

      Pages: 163-167

    • NAID

      120005419286

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Bovine colostral antibody against verotoxin 2 derived from Escherichia coli O157 : H7 : Resistance to proteases and effects inbeagle dogs2009

    • Author(s)
      Takashi Kuribayashi
    • Journal Title

      Comparative Medicine 59

      Pages: 163-167

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] Neutralizing efficacy and resistance to intestinal proteases of bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157:H72010

    • Author(s)
      山本静熊
    • Organizer
      The Society for Applied microbiology Summer Conference
    • Place of Presentation
      Brighton, UK
    • Related Report
      2010 Annual Research Report
  • [Presentation] Resistance to proteases of bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157 : H7 in small intestine of beagle dogs2009

    • Author(s)
      Kuribayashi T., Yamamoto S.
    • Organizer
      第39回日本免疫学会総会・学術集会
    • Place of Presentation
      大阪
    • Related Report
      2010 Final Research Report
  • [Presentation] Bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157 : H7-Resistance to proteases and effects on verotoxin 2 in small intestine of beagle dogs-2009

    • Author(s)
      Yamamoto S., Kuribayashi T., Seita T., Furuhata K., Tagata K.
    • Organizer
      49th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Place of Presentation
      San Francisco, USA
    • Related Report
      2010 Final Research Report
  • [Presentation] Bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157:H72009

    • Author(s)
      Takashi Kuribayashi
    • Organizer
      3rd Congress of European Microbiologists
    • Place of Presentation
      Gothenburg, Sweden
    • Related Report
      2009 Annual Research Report
  • [Presentation] Bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157:H7 - Resistance to proteases and effects on verotoxin 2 in small intestine of beagle dogs2009

    • Author(s)
      Shizuo Yamamoto
    • Organizer
      The 49th Interscience Conference on Antimicrobial Agents and Chmotherapy
    • Place of Presentation
      San Francisco, USA
    • Related Report
      2009 Annual Research Report
  • [Presentation] Resistance to proteases of bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157:H7 in small intestine of beagle dogs2009

    • Author(s)
      Takashi Kuribayashi
    • Organizer
      第39回日本免疫学会・学術総会
    • Place of Presentation
      大阪
    • Related Report
      2009 Annual Research Report
  • [Presentation] Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157 : H7 in mice2008

    • Author(s)
      Kuribayashi T., Yamamoto S.
    • Organizer
      The 21st International ICFMH Symposium
    • Place of Presentation
      Aberdeen, UK
    • Related Report
      2010 Final Research Report
  • [Presentation] The bovine colostral antibody neutralized activity of verotoxin derived from enterohemorrhagic Escherichia coli O157 : H7 in mice2008

    • Author(s)
      Kuribayashi T., Yamamoto S.
    • Organizer
      第38回日本免疫学会総会・学術集会
    • Place of Presentation
      京都
    • Related Report
      2010 Final Research Report 2008 Annual Research Report
  • [Presentation] Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157 : H7 in mice2008

    • Author(s)
      Takashi Kuribayashi
    • Organizer
      The 21st International ICFMH Symposium
    • Place of Presentation
      Aberdeen, 英国
    • Related Report
      2008 Annual Research Report
  • [Presentation] Neutralizing efficacy and resistance to intestinal proteases of bovine immune colostral antibody against verotoxin 2 derived from Escherichia coli O157 : H7

    • Author(s)
      Yamamoto S., Kuribayashi T., Seita T, Sakurai Y., Kawaguchi Y., Matsuda M
    • Organizer
      The Society for Applied microbiology Summer Conference
    • Place of Presentation
      Brigton, UK
    • Related Report
      2010 Final Research Report
  • [Remarks] ホームページ等

    • Related Report
      2010 Final Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi